Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of secretion and spreading of pathological tau protein
Cecilia A. Brunello, Maria Merezhko, Riikka‐Liisa Uronen, et al.
Cellular and Molecular Life Sciences (2019) Vol. 77, Iss. 9, pp. 1721-1744
Open Access | Times Cited: 252

Showing 1-25 of 252 citing articles:

The expanding amyloid family: Structure, stability, function, and pathogenesis
M.R. Sawaya, Michael P. Hughes, José A. Rodríguez, et al.
Cell (2021) Vol. 184, Iss. 19, pp. 4857-4873
Open Access | Times Cited: 270
Alzheimer’s disease brain-derived extracellular vesicles spread tau pathology in interneurons
Zhi Ruan, Dhruba Pathak, Srinidhi Venkatesan Kalavai, et al.
Brain (2020) Vol. 144, Iss. 1, pp. 288-309
Open Access | Times Cited: 198
Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
Priyanka Rawat, Ujala Sehar, Jasbir Bisht, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12841-12841
Open Access | Times Cited: 187
Role of tau protein in Alzheimer's disease: The prime pathological player
Shibi Muralidar, Senthil Visaga Ambi, Saravanan Sekaran, et al.
International Journal of Biological Macromolecules (2020) Vol. 163, pp. 1599-1617
Closed Access | Times Cited: 178
Amyloid-type Protein Aggregation and Prion-like Properties of Amyloids
Dieter Willbold, Birgit Strodel, Gunnar F. Schröder, et al.
Chemical Reviews (2021) Vol. 121, Iss. 13, pp. 8285-8307
Open Access | Times Cited: 153
Acetylated tau inhibits chaperone-mediated autophagy and promotes tau pathology propagation in mice
Benjamı́n Caballero, Mathieu Bourdenx, Enrique Luengo, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 146
ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease
Petr Novák, Branislav Kováčech, Stanislav Katina, et al.
Nature Aging (2021) Vol. 1, Iss. 6, pp. 521-534
Closed Access | Times Cited: 125
Role of natural products for the treatment of Alzheimer's disease
Tayebeh Noori, Ahmad Reza Dehpour, Antoni Sureda, et al.
European Journal of Pharmacology (2021) Vol. 898, pp. 173974-173974
Closed Access | Times Cited: 120
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease
Nicholas J. Ashton, Andréa Lessa Benedet, Tharick A. Pascoal, et al.
EBioMedicine (2022) Vol. 76, pp. 103836-103836
Open Access | Times Cited: 119
Revisiting the grammar of Tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target Tauopathies
Galina Limorenko, Hilal A. Lashuel
Chemical Society Reviews (2021) Vol. 51, Iss. 2, pp. 513-565
Open Access | Times Cited: 113
Biomolecular condensates can both accelerate and suppress aggregation of α-synuclein
Wojciech P. Lipiński, Brent S. Visser, Irina Robu, et al.
Science Advances (2022) Vol. 8, Iss. 48
Open Access | Times Cited: 76
Tau deposition patterns are associated with functional connectivity in primary tauopathies
Nicolai Franzmeier, Matthias Brendel, Leonie Beyer, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 72
Tilavonemab in early Alzheimer’s disease: results from a phase 2, randomized, double-blind study
Hana Florian, Deli Wang, Steven E. Arnold, et al.
Brain (2023) Vol. 146, Iss. 6, pp. 2275-2284
Open Access | Times Cited: 64
Heterotypic electrostatic interactions control complex phase separation of tau and prion into multiphasic condensates and co-aggregates
K. Sandeep, Roopali Khanna, Anamika Avni, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 2
Open Access | Times Cited: 45
Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease
Nicolai Franzmeier, Amir Dehsarvi, Anna Steward, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 21
The six brain‐specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes
Sarah Buchholz, Hans Zempel
Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3606-3628
Open Access | Times Cited: 20
P-tau217 correlates with neurodegeneration in Alzheimer’s disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy
Denghong Zhang, Wei Zhang, Ming Chen, et al.
Neuron (2024) Vol. 112, Iss. 10, pp. 1676-1693.e12
Closed Access | Times Cited: 19
Current Progress and Future Directions in Non-Alzheimer’s Disease Tau PET Tracers
Hendris Wongso, Ryuichi Harada, Shozo Furumoto
ACS Chemical Neuroscience (2025) Vol. 16, Iss. 2, pp. 111-127
Closed Access | Times Cited: 2
Targeting Tau Protein with Proximity Inducing Modulators: A New Frontier to Combat Tauopathies
Elisa Uliassi, María Laura Bolognesi, Andrea Milelli
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 3, pp. 654-672
Closed Access | Times Cited: 2
Extracellular Monomeric Tau Is Internalized by Astrocytes
Juan Ramón Perea, Esther López, José C. Díez, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 100
Microglia in Alzheimer’s Disease in the Context of Tau Pathology
Juan Ramón Perea, Marta Bolós, Jesús Ávila
Biomolecules (2020) Vol. 10, Iss. 10, pp. 1439-1439
Open Access | Times Cited: 84
The effect of insomnia on development of Alzheimer’s disease
Shaghayegh Sadeghmousavi, Mahsa Eskian, Farzaneh Rahmani, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 80
Possible Mechanisms of Tau Spread and Toxicity in Alzheimer’s Disease
Huiqin Zhang, Yu Cao, Lina Ma, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 78
Therapeutic Potential of Vital Transcription Factors in Alzheimer’s and Parkinson’s Disease With Particular Emphasis on Transcription Factor EB Mediated Autophagy
Sachchida Nand, Neeraj Tiwari, Payal Singh, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 74
Promiscuous Roles of Autophagy and Proteasome in Neurodegenerative Proteinopathies
Fiona Limanaqi, Francesca Biagioni, Stefano Gambardella, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 3028-3028
Open Access | Times Cited: 72
Page 1 - Next Page

Scroll to top